|
|
Volumn 98, Issue 2, 2006, Pages 86-87
|
|
Latest studies hint at survival advantage with aromatase inhibitors in early breast cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANASTROZOLE;
AROMATASE INHIBITOR;
LETROZOLE;
PLACEBO;
TAMOXIFEN;
TAMOXIFEN CITRATE;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER RECURRENCE;
CANCER RELAPSE;
CANCER RESEARCH;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG SUBSTITUTION;
EARLY CANCER;
HUMAN;
NOTE;
POSTMENOPAUSE;
PRIORITY JOURNAL;
RECURRENCE RISK;
RISK REDUCTION;
ANTINEOPLASTIC AGENTS, HORMONAL;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
EUROPE;
FEMALE;
HUMANS;
META-ANALYSIS;
NEOPLASM RECURRENCE, LOCAL;
NITRILES;
POSTMENOPAUSE;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL ANALYSIS;
SURVIVAL RATE;
TREATMENT OUTCOME;
TRIAZOLES;
|
|
EID: 31544470597
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djj043 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|